Stay updated on Dupilumab in Children With Asthma Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Children With Asthma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a system-wide notice about government funding affecting site operations and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-03T23:55:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page update includes UI and metadata changes: showing a glossary, adding Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, capitalization tweaks for No FEAR Act Data, and a revision label of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T22:44:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: added v3.3.4 and removed v3.3.3 from the page to reflect the latest documentation version. This is a metadata update and does not alter core study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:38.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updated the study locations: new sites were added across multiple regions (US and international). Several existing locations were removed, changing the geographic options for enrollment.
    Difference
    2%
    Check dated 2025-12-23T17:25:37.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Results for the study have been posted, including TEAEs and a range of efficacy and safety measures for the main study and the Japan sub-study through Week 64. Data include FEV1, IgE, ADA, dupilumab serum concentrations, and ACQ-IA/ACQ-5-IA outcomes.
    Difference
    3%
    Check dated 2025-11-24T21:35:33.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    - The lapse in government funding notice about potential data delays and outdated information has been removed. - It previously warned that updates and responses might be affected until appropriations are enacted.
    Difference
    0.2%
    Check dated 2025-11-17T19:51:30.000Z thumbnail image

Stay in the know with updates to Dupilumab in Children With Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.